Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Dermatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-blind, Randomized Withdrawal Extension Study of Subcutaneous Secukinumab in Prefilled Syringes to Demonstrate Long-term Efficacy, Safety, and Tolerability up to 4 Years in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
INTERVENTIONAL
Inicio: 19 de jun de 2012
ID: NCT01544595
Activo, no recluta
Fase 2
ClinicalTrials.gov
Effisayil™ ON: An Open-label, Long Term Extension Study to Assess the Safety and Efficacy of Spesolimab Treatment in Patients With Generalized Pustular Psoriasis (GPP)
INTERVENTIONAL
Inicio: 29 de may de 2019
ID: NCT03886246
Completado
Fase 2
ClinicalTrials.gov
A Phase II Prospective, Open Label, Randomized, Active-controlled, Parallel Group, Multi-center 'Proof of Concept' Trial in Adult Patients With Complicated Skin or Skin Structure Infections Requiring Hospitalization.
INTERVENTIONAL
Inicio: 1 de dic de 2005
ID: NCT00303589
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes (SUSTAIN™ 2 - vs. DPP-4 Inhibitor)
INTERVENTIONAL
Inicio: 2 de dic de 2013
ID: NCT01930188
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Multicenter, Placebo-controlled, Phase III Superiority Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Placebo Ointment Applied Twice Daily for 5 Days in the Treatment of Adult and Pediatric Subjects With SITL
INTERVENTIONAL
Inicio: 1 de may de 2008
ID: NCT00684177
Completado
Fase 2
ClinicalTrials.gov
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
INTERVENTIONAL
Inicio: 20 de oct de 2016
ID: NCT02847598
Terminado
Fase 3
ClinicalTrials.gov
A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin
INTERVENTIONAL
Inicio: 11 de jun de 2014
ID: NCT02131272
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Multicenter Study Comparing MDX-010 Monotherapy, MDX-010 in Combination With a Melanoma Peptide Vaccine, and Melanoma Vaccine Monotherapy in HLA-A2*0201-Positive Patients With Previously Treated Unresectable Stage III or IV Melanoma
INTERVENTIONAL
Inicio: 1 de sept de 2004
ID: NCT00094653
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study With a Randomized Withdrawal and Retreatment Period to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis
INTERVENTIONAL
Inicio: 6 de nov de 2023
ID: NCT06108544
Completado
Fase 4
ClinicalTrials.gov
A 26-week Randomised, Controlled, Open Label, Multicentre, Multinational, Treat to Target Trial Investigating the Impact of Dietary Intervention on Weight Change and the Relationship Between Weight Change and Baseline Body Mass Index (BMI) in Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) Initiating Insulin Therapy With Insulin Detemir in Combination With Metformin (Levemir DIET)
INTERVENTIONAL
Inicio: 29 de oct de 2010
ID: NCT01232491
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas
INTERVENTIONAL
Inicio: 12 de oct de 2023
ID: NCT06095102
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Double-blind, Placebo-controlled, Randomized Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Patients With Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
INTERVENTIONAL
Inicio: 25 de nov de 2019
ID: NCT04177108
Terminado
ClinicalTrials.gov
Use of Corticosteroids in Children Hospitalized With Cellulitis: Randomized, Double Blind, Placebo Controlled Trial
INTERVENTIONAL
Inicio: 1 de jun de 2014
ID: NCT02087527
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lebrikizumab in Adult and Adolescent Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis
INTERVENTIONAL
Inicio: 21 de abr de 2025
ID: NCT06921759
Completado
Fase 3
ClinicalTrials.gov
A Long-term, Randomised, Double-blind, Placebo-controlled, Multinational, Multi-centre Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes (SUSTAIN™ 6 - Long-term Outcomes)
INTERVENTIONAL
Inicio: 21 de feb de 2013
ID: NCT01720446
Completado
Fase 3
ClinicalTrials.gov
A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis
INTERVENTIONAL
Inicio: 3 de mar de 2015
ID: NCT02376790
Completado
Fase 3
ClinicalTrials.gov
A 26-week Double Blinded, Multiregional, Trial Comparing the Effect and Safety of Once Weekly Insulin Icodec and Once Daily Insulin Degludec 100 Units/mL, Both in Combination With Non-insulin Anti-diabetic Drugs, in Insulin naïve Subjects With Type 2 Diabetes.
INTERVENTIONAL
Inicio: 24 de mar de 2021
ID: NCT04795531
Completado
Fase 3
ClinicalTrials.gov
A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification (DUAL™ - Intensification)
INTERVENTIONAL
Inicio: 1 de abr de 2014
ID: NCT02100475
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Systemic Sclerosis
INTERVENTIONAL
Inicio: 6 de feb de 2025
ID: NCT06843239
Activo, no recluta
Fase 3
ClinicalTrials.gov
The Effect of Semaglutide in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis
INTERVENTIONAL
Inicio: 1 de abr de 2021
ID: NCT04822181
Anterior
1
...
8
9
10
...
434
Siguiente
Filtros